Danilon Equidos is a non-steroidal anti-inflammatory drug for treatment of pain and inflammation associated with musculoskeletal conditions in the horse eg. osteoarthritic conditions, bursitis, laminitis and soft tissue inflammation.
Sachets containing 10g of granules. Each sachet contains 1.5 g of Suxibuzone (microencapsulated).
For oral administration added to a small amount of feed. Ensure free access to drinking water during treatment.
Horses: For a 480 kg horse: administer 2 sachets twice daily for 2 days. This is equivalent to 12.5 mg suxibuzone/kg/day. Follow by administering 1 sachet twice daily for 3 days (equivalent to 6.25 mg suxibuzone/kg/day). Thereafter, administer 1 sachet daily or on alternate days, in order to achieve the desired clinical response (equivalent to 3.1 mg suxibuzone/kg/day). Thereafter, reduce the dose to the minimum dose necessary for a satisfactory clinical response.
Ponies: Administer half the recommended dose for horses. Adjust the dose carefully according to bodyweight. For a 240 kg pony: administer 1 sachet daily for 2 days (equivalent to 6.25 mg of suxibuzone/kg/day). Follow by administering ½ sachet daily for 3 days (equivalent to 3.1 mg of suxibuzone/kg/day) or 1 sachet daily on alternate days. Thereafter, reduce the dose to the minimum dose necessary for a satisfactory clinical response.
Further administration advice: For administration of half sachets, use the measuring scoop provided. One level scoop contains 5 g granules. Hay, as part of the diet, may delay the absorption of suxibuzone and so the onset of the clinical effect. It is advisable not to feed hay immediately prior to, or with Danilon Equidos. If no clinical response is evident after 4-5 days of treatment, discontinue treatment and reconsider the diagnosis
To ensure that you read the most up to date information about this product, please check the VMD's Product Information Database.